‘Immunomodulatory’ approaches to the management of antiphospholipid syndrome

Abstract

1 ISSN 1758-4272 10.2217/IJR.11.77 © 2012 Future Medicine Ltd Int. J. Clin. Rheumatol. (2012) 7(1), 1–4 “The use of immunomodulatory agents has revolutionized the management of many autoimmune diseases including rheumatoid arthritis and SLE. Despite the comparatively slow pace of implementing these therapeutic agents in the management of APS patients, the last few years have produced several excellent clinical studies highlighting the efficacy of these drugs as well as international collaborative initiatives dedicated to furthering APS research.”